Keytruda/Lenvima Trials Stop Due to Lack of Benefit : vimars

Two clinical trials investigating Keytruda plus Lenvima will be discontinued after the drug duo was not superior to other regimens for melanoma and colorectal cancer subsets.

Related Keywords

Keytruda Lenvima , Gregory Lubiniecki , Corina Dutcus , Merck Research Laboratories , Global Clinical Development , Eisai Inc , Vice President , Skin Cancer , Colorectal Cancer ,